ENP112: Osteoporosis and the SABRE Project

Endocrine News Podcast by Endocrine Society

May 18, 202624:00Science & Medicine

The U.S. Food and Drug Administration recently qualified "total hip bone mineral density" as a surrogate endpoint to support clinical trials for osteoporosis drugs. This decision will significantly impact clinical trials...

Related Episodes

Continue listening to more episodes from Endocrine News Podcast.

Bisphenols and the Thyroid

Aug 14, 2026 - 11:39

This episode looks at bisphenols and the thyroid, asking questions such as: What is BPA? Where is it foun...

Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments

Aug 3, 2026 - 20:04

Estrogen receptor positive breast cancer (ER+ BC) is the most frequently diagnosed subtype of BC with con...

ENP113: Clinical Practice Guideline on Central Precocious Puberty

Jun 25, 2026 - 17:40

The Endocrine Society recently released a new Clinical Practice Guideline (CPG) on Central Precocious Pub...

ENP111: Addressing the Endocrine Workforce Shortage

Feb 25, 2026 - 30:12

The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat....

ENP110: Hypercortisolism and T2D

Jan 21, 2026 - 20:03

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies....

ENP109: Anti-Obesity Medications (CME credit available)

Jan 7, 2026 - 13:15

In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, b...

ENP108: AI and Robotics in Surgery

Dec 17, 2025 - 10:28

In the last five years, the field of artificial intelligence and robotics has taken off and has become a...

ENP107: Compounded Obesity Medications

Dec 3, 2025 - 11:49

Technically known as glucagon-like peptide-1 receptor agonists, or GLP-1, these drugs have been around fo...